
1001 - 5000 employees
Founded 2003
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative medicines that address serious unmet medical needs. With a strong commitment to research and development, Jazz focuses on creating life-changing therapies, emphasizing the importance of collaboration, diversity, and employee engagement in its operations. The company prides itself on transforming patients' lives through its meaningful product offerings and a culture that fosters enthusiasm and flexibility.
🔥 0 minutes ago
🌐 United States, United Kingdom – Remote
🏄 California, Pennsylvania – Remote
💵 $212k - $318k / year
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
👻 Ghost score 0%
Where this job comes from
Posted on Jazz Pharmaceuticals's careers page, not through a job board
First seen by Remote Rocketship 0 minutes ago

1001 - 5000 employees
Founded 2003
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative medicines that address serious unmet medical needs. With a strong commitment to research and development, Jazz focuses on creating life-changing therapies, emphasizing the importance of collaboration, diversity, and employee engagement in its operations. The company prides itself on transforming patients' lives through its meaningful product offerings and a culture that fosters enthusiasm and flexibility.
• Lead global and US payer evidence strategy across marketed assets in Jazz’s neurology portfolio • Maximize brand potential, defend value, secure expanded access, and drive evidence generation across the post-launch lifecycle • Translate commercial, access, and policy priorities into evidence generation plans and deliverables • Lead HEOR evidence strategies supporting supplemental regulatory filings, new indications, line extensions, expanded subpopulations, and novel formulations/devices • Optimize Phase 3b/4 trials, pragmatic studies, and expanded access programs with payer-relevant endpoints, PROs, and HRQoL measures • Partner with Market Access on indication sequencing and access strategy • Lead rare disease registries, natural history extensions, and post-authorization safety/efficacy studies • Design comparative effectiveness, adherence, burden-of-illness, and real-world data studies to defend product value • Co-create HTA re-assessment strategies and deliver updated NMAs, ITCs, economic models, and evidence packages • Direct updates of Global Value Dossiers, systematic literature reviews, and meta-analyses • Serve as designated US HEOR expert for assigned inline products • Lead AMCP dossiers, unbranded value summaries, and state Medicaid submission dossiers • Develop and train teams on interactive economic models and reactive scientific presentations • Ensure US HEOR deliverables comply with FDAMA Section 114, the 21st Century Cures Act, and FDA HCEI guidance • Evaluate outcomes-based risk-sharing agreements and establish real-world endpoint tracking frameworks • Monitor US health policy and prepare evidence plans and materials for ICER and other value assessment bodies • Build and adapt cost-effectiveness, cost-utility, budget impact, cost-offset, Markov, partitioned survival, microsimulation, and dynamic population models • Govern Integrated Evidence Generation Plans for inline assets • Partner with Market Access, Medical Affairs, Commercial Brand, Regulatory Affairs, Biostatistics, and RWE teams • Lead publications and conference presentations at ISPOR, AMCP, and disease-specific congresses • Manage vendors, consultancies, academic partners, CROs, budgets, quality, timelines, and compliance • Provide mentorship and technical guidance to associate directors, managers, and fellows
• Master’s degree (MSc, MS, MPH) or PhD in Health Economics, Outcomes Research, Pharmacoeconomics, or a closely related quantitative field • Minimum of 7–10 years of experience in HEOR, Global Value, or Health Economics within the biopharmaceutical industry or a top-tier HEOR consulting firm • Extensive experience designing and executing post-marketing HEOR strategies, real-world comparative effectiveness studies, and evidence roadmaps supporting label expansions, line extensions, and value defense • Comprehensive working knowledge of the US managed care landscape and global HTA environments • Proven technical expertise building, adapting, and validating economic models, including Markov, partitioned survival, microsimulation, and dynamic budget impact models • Proven track record collaborating with US Market Access, Pricing/Contracting, and Payer Field Teams • Demonstrated understanding of rare disease and orphan product post-launch evidence challenges • Working knowledge of major US and global healthcare databases and advanced epidemiological methods • Ability to balance evidence strategy with hands-on execution of complex technical deliverables • Exceptional verbal, written, and presentation skills • Demonstrated ability to influence cross-functional matrix teams and defend methodologies before payers, HTA authorities, and scientific reviewers • Experience with neurology assets preferred • Demonstrated track record leading HEOR strategy and executing evidence deliverables for marketed pharmaceutical products • Launch lead for at least 2 assets as US HEOR lead, or country-level HTA lead • Experience conducting post-marketing RWE, patient registry studies, and economic evaluations in rare diseases, specialized medicine, or complex chronic conditions • Substantial experience collaborating with regional HEOR teams to deliver global HTA re-assessment packages • Strong peer-reviewed publication record in health economics and outcomes research
• Discretionary annual cash bonus or incentive compensation • Discretionary equity grants through the Long Term Equity Incentive Plan • Medical insurance • Dental insurance • Vision insurance • 401k retirement savings plan • Flexible paid vacation
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🔥 5 minutes ago
Product Delivery Director guiding Voya’s Employee Benefits technology roadmap and delivery. Leading prioritization, readiness, testing, adoption, and stakeholder alignment for financial-services solutions.
🔥 1 hour ago
Pfizer director translating specialty-care patient engagement strategy into compliant GTM plans, targeting models, and field execution. Driving launches, analytics, governance, and cross-functional enablement.
🇺🇸 United States – Remote
💵 $176.6k - $294.3k / year
💰 Post-IPO Debt on 2023-05
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🔥 1 hour ago
Director leading Palo Alto Networks’ NGFW and SASE growth through MSP, MSSP, and GSI partnerships. Building offerings, routes to market, and partner-led pipeline.
🇺🇸 United States – Remote
💵 $273.6k - $319.2k / year
💰 $1M Seed Round - Morta Security on 2013-02
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🔥 2 hours ago
WelbeHealth IT director leading enterprise technology portfolios, governance, and delivery. Aligning investments, budgets, and delivery practices to improve care for vulnerable seniors.
🇺🇸 United States – Remote
💵 $159.9k - $211.1k / year
💰 $30M Series C on 2020-02
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🔥 2 hours ago
RCM director launching Practice by Numbers’ dental revenue cycle business. Building US and India teams, workflows, client services and revenue growth operations.